Search Results
A message from our chief kairos officer, Nick Leschly
A message from our chief scientific officer, Philip Gregory, D. Phil
Founder Stories: Nick Leschly, CEO of Blurbird Bio & The Promise of Gene Therapy
Labiotech Tour Boston 2014: Bluebird with CEO, Nick Leschly
better2gether
Mark Leschly at World Tennis Conference 2021 (German Subtitles)
2seventy bio, Inc. (TSVTV) NasdaqGS - NasdaqGS Real Time Price
Life Science Today 093 - 2seventy Bio, Ascendis, Apellis, Argenx
Life Science Today 100 – Pfizer + Biohaven, Regulators, Lilly, BridgeBio + BMS
The Niche Episode 068 – Eli Lilly + ProQR, Sanofi + Kadmon, Lycia, BlueBird + 2seventy, Mammoth
Plenary Session: The Realities of Bringing Gene Therapies to Market
SAVA P3 Update, GALT Doubles Again, LIXT Doubles Fighting Cancer w/ Cancer, NANC KRUZ Launch
